{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T01:11:46Z","timestamp":1768007506222,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.cca.2017.02.017","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T18:01:07Z","timestamp":1487959267000},"page":"140-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction"],"prefix":"10.1016","volume":"468","author":[{"given":"Kun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.02.017_bb0005","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.114.302744","article-title":"Reperfusion strategies in acute coronary syndromes","volume":"114","author":"Bagai","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2017.02.017_bb0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2017.02.017_bb0015","first-page":"III20","article-title":"Inflammation in atherosclerosis and implications for therapy","volume":"125","author":"Paoletti","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2017.02.017_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.cca.2017.02.017_bb0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ni.2406","article-title":"From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines","volume":"13","author":"Banchereau","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0030","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/cei.12284","article-title":"Interleukin-37 ameliorates myocardial ischaemia\/reperfusion injury in mice","volume":"176","author":"Wu","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0040","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/eji.201545828","article-title":"Suppression of innate inflammation and immunity by interleukin-37","volume":"46","author":"Dinarello","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0045","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/1744666X.2014.971014","article-title":"Immunobiology of IL-37: mechanism of action and clinical perspectives","volume":"10","author":"Quirk","year":"2014","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0050","doi-asserted-by":"crossref","first-page":"626934","DOI":"10.1155\/2015\/626934","article-title":"The evaluation of plasma and leukocytic IL-37 expression in early inflammation in patients with acute ST-segment elevation myocardial infarction after PCI","volume":"2015","author":"Wang","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2017.02.017_bb0055","doi-asserted-by":"crossref","first-page":"165742","DOI":"10.1155\/2014\/165742","article-title":"Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome","volume":"2014","author":"Ji","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cca.2017.02.017_bb0060","first-page":"805375","article-title":"Elevated circulating levels of inflammatory markers in patients with acute coronary syndrome","volume":"2015","author":"Al Shahi","year":"2015","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.cca.2017.02.017_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6612-4_15","article-title":"Pathogenic role of IL-6 combined with TNF-alpha or IL-1 in the induction of acute phase proteins SAA and CRP in chronic inflammatory diseases","volume":"691","author":"Yoshizaki","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cca.2017.02.017_bb0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2143\/AC.65.3.2050343","article-title":"Effects of fluvastatin therapy on serum interleukin-18 and interleukin-10 levels in patients with acute coronary syndrome","volume":"65","author":"Liu","year":"2010","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.cca.2017.02.017_bb0075","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/hh0901.090440","article-title":"Anti-inflammatory mechanisms in the vascular wall","volume":"88","author":"Tedgui","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2017.02.017_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2014.10.088","article-title":"Treg\/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis","volume":"238","author":"Potekhina","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2017.02.017_bb0085","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","article-title":"Monocytes in coronary artery disease and atherosclerosis: where are we now?","volume":"62","author":"Ghattas","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cca.2017.02.017_bb0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.cca.2017.02.017_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/039463201202500105","article-title":"IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation","volume":"25","author":"Tete","year":"2012","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cca.2017.02.017_bb0100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cca.2017.02.017_bb0105","first-page":"857","article-title":"The potential role of IL-37 in atherosclerosis","volume":"68","author":"Wu","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.cca.2017.02.017_bb0110","article-title":"Protective effect of the polarity of macrophages regulated by IL-37 on atherosclerosis","volume":"15","author":"Huang","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.cca.2017.02.017_bb0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/sji.12322","article-title":"Increased IL-37 in atherosclerotic disease could be suppressed by atorvastatin therapy","volume":"82","author":"Shaoyuan","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cca.2017.02.017_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1189\/jlb.0904484","article-title":"New insights into the molecular mechanism of interleukin-10-mediated immunosuppression","volume":"77","author":"Grutz","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cca.2017.02.017_bb0125","first-page":"5247","article-title":"Effects of interleukin-37 on cardiac function after myocardial infarction in mice","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T02:37:09Z","timestamp":1601692629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117300694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":25,"alternative-id":["S0009898117300694"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.02.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}